← Evidence map

ArticleRheumatology and therapy2026

Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.

Michele Maria Luchetti Gentiloni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study. | OpenQuestion